Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MTCO3P15 (mitochondrially encoded cytochrome c oxidase III pseudogene 15) is classified as a pseudogene located on human chromosome 11 (locus 11q22.3)[7][5][2]. It is a non-coding genomic segment that is similar in sequence to the functional MT-CO3 gene but is not thought to produce a functional or active protein product and is not involved in the mitochondrial electron transport chain. As a pseudogene, MTCO3P15 is not considered a therapeutic target, has no established molecular function, disease association, biomarker role, known interacting drugs, or safety concerns[2][5][7]. Its annotation is primarily of genomic and evolutionary interest, and it is distinct from the protein-coding gene MT-CO3, which encodes an essential component of respiratory complex IV[1][6][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrially encoded cytochrome c oxidase III pseudogene 15 (MTCO3P15).